Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial
Jean‐Yves Blay, César Serrano, Michael C. Heinrich, John Zalcberg, Sebastian Bauer, Hans Gelderblom, Patrick Schöffski, Robin L. Jones, Steven Attia, Gina Z. D’Amato, Ping Chi, Peter Reichardt, Julie Meade, Kelvin Shi, Rodrigo Ruiz‐Soto, Suzanne George, Margaret von Mehren
Topics & Concepts
MedicineSunitinibPlaceboInternal medicineRegorafenibClinical endpointGiSTOncologyImatinibTyrosine-kinase inhibitorPopulationAdverse effectClinical trialPDGFRAImatinib mesylateCancerStromal cellPathologyColorectal cancerAlternative medicineEnvironmental healthMyeloid leukemiaGastrointestinal Tumor Research and TreatmentGastrointestinal Bleeding Diagnosis and TreatmentGastrointestinal disorders and treatments